Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Chng

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Medical Physics|March 3, 2011
Prostate brachytherapy postimplant dosimetry: automatic plan reconstruction of stranded implantsN Chng, I Spadinger, W J Morris, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 2022
Validation of the Prognostic Utility of ESTRO/EORTC Oligometastatic Disease Classification: A Secondary Analysis From the Population-Based Phase II SABR-5 TrialS Baker, B Mou, W Jiang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 9, 2026
Population-Based Outcomes of Single-Fraction Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung CancerJ M Callueng, S Baker, N Chng, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 31, 2024
Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase II TrialE M Cruz-Lim, B Mou, W Jiang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 13, 2023
Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II TrialE M Cruz-Lim, B Mou, S Baker, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Medical Physics|March 3, 2011
Prostate brachytherapy postimplant dosimetry: automatic plan reconstruction of stranded implantsN Chng, I Spadinger, W J Morris, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 2022
Validation of the Prognostic Utility of ESTRO/EORTC Oligometastatic Disease Classification: A Secondary Analysis From the Population-Based Phase II SABR-5 TrialS Baker, B Mou, W Jiang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 9, 2026
Population-Based Outcomes of Single-Fraction Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung CancerJ M Callueng, S Baker, N Chng, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 31, 2024
Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase II TrialE M Cruz-Lim, B Mou, W Jiang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 13, 2023
Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II TrialE M Cruz-Lim, B Mou, S Baker, et al.
Pageof 1